1. Home
  2. ROIV vs EDU Comparison

ROIV vs EDU Comparison

Compare ROIV & EDU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ROIV
  • EDU
  • Stock Information
  • Founded
  • ROIV 2014
  • EDU 1993
  • Country
  • ROIV United Kingdom
  • EDU China
  • Employees
  • ROIV N/A
  • EDU N/A
  • Industry
  • ROIV Biotechnology: Pharmaceutical Preparations
  • EDU Other Consumer Services
  • Sector
  • ROIV Health Care
  • EDU Real Estate
  • Exchange
  • ROIV Nasdaq
  • EDU Nasdaq
  • Market Cap
  • ROIV 7.8B
  • EDU 7.3B
  • IPO Year
  • ROIV N/A
  • EDU 2006
  • Fundamental
  • Price
  • ROIV $10.99
  • EDU $47.39
  • Analyst Decision
  • ROIV Buy
  • EDU Hold
  • Analyst Count
  • ROIV 4
  • EDU 4
  • Target Price
  • ROIV $17.50
  • EDU $48.50
  • AVG Volume (30 Days)
  • ROIV 5.1M
  • EDU 758.7K
  • Earning Date
  • ROIV 05-29-2025
  • EDU 04-23-2025
  • Dividend Yield
  • ROIV N/A
  • EDU 1.23%
  • EPS Growth
  • ROIV N/A
  • EDU 27.46
  • EPS
  • ROIV N/A
  • EDU 2.29
  • Revenue
  • ROIV $29,053,000.00
  • EDU $4,793,786,000.00
  • Revenue This Year
  • ROIV N/A
  • EDU $13.48
  • Revenue Next Year
  • ROIV N/A
  • EDU $12.89
  • P/E Ratio
  • ROIV N/A
  • EDU $20.67
  • Revenue Growth
  • ROIV N/A
  • EDU 18.73
  • 52 Week Low
  • ROIV $8.73
  • EDU $40.66
  • 52 Week High
  • ROIV $13.06
  • EDU $87.26
  • Technical
  • Relative Strength Index (RSI)
  • ROIV 52.59
  • EDU 48.73
  • Support Level
  • ROIV $10.59
  • EDU $46.64
  • Resistance Level
  • ROIV $11.37
  • EDU $49.72
  • Average True Range (ATR)
  • ROIV 0.32
  • EDU 0.98
  • MACD
  • ROIV -0.01
  • EDU -0.12
  • Stochastic Oscillator
  • ROIV 52.23
  • EDU 37.00

About ROIV Roivant Sciences Ltd.

Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.

About EDU New Oriental Education & Technology Group Inc.

New Oriental is a prominent private education provider in China, offering a wide array of educational services. These include overseas test preparation, consulting services, high school academic tutoring, nonacademic tutoring, and intelligent learning systems and devices. Additionally, the company holds a 57% ownership stake in East Buy, a leading player in the livestreaming e-commerce market.

Share on Social Networks: